ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 316 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $327,787 | -24.6% | 12,199 | 0.0% | 0.06% | -22.2% |
Q2 2023 | $435,016 | +12.7% | 12,199 | -19.7% | 0.07% | +5.9% |
Q1 2023 | $386,055 | -37.4% | 15,199 | 0.0% | 0.07% | -41.9% |
Q4 2022 | $616,471 | +20.6% | 15,199 | -1.6% | 0.12% | +9.3% |
Q3 2022 | $511,000 | -6.1% | 15,448 | 0.0% | 0.11% | +0.9% |
Q2 2022 | $544,000 | -23.5% | 15,448 | -0.0% | 0.11% | -12.4% |
Q1 2022 | $711,000 | -30.6% | 15,453 | 0.0% | 0.12% | -32.8% |
Q4 2021 | $1,025,000 | +6.2% | 15,453 | 0.0% | 0.18% | -3.7% |
Q3 2021 | $965,000 | -24.6% | 15,453 | 0.0% | 0.19% | -25.5% |
Q2 2021 | $1,280,000 | +27.9% | 15,453 | +2.4% | 0.25% | +15.7% |
Q1 2021 | $1,001,000 | -13.6% | 15,089 | 0.0% | 0.22% | -19.3% |
Q4 2020 | $1,158,000 | +78.2% | 15,089 | 0.0% | 0.27% | +52.8% |
Q3 2020 | $650,000 | -0.3% | 15,089 | 0.0% | 0.18% | -3.8% |
Q2 2020 | $652,000 | +50.2% | 15,089 | 0.0% | 0.18% | +21.2% |
Q1 2020 | $434,000 | -54.6% | 15,089 | 0.0% | 0.15% | -43.4% |
Q4 2019 | $957,000 | +126.2% | 15,089 | +0.6% | 0.27% | +107.0% |
Q3 2019 | $423,000 | +59.6% | 15,000 | +50.0% | 0.13% | +61.2% |
Q2 2019 | $265,000 | +44.0% | 10,000 | 0.0% | 0.08% | +40.4% |
Q1 2019 | $184,000 | +48.4% | 10,000 | 0.0% | 0.06% | +26.7% |
Q4 2018 | $124,000 | – | 10,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |